Dr. Vervloet cardiologist at AZ Maria Middelares delves into the theoretical impact of the ESC guidelines1 2for the management of HF patients.
In the theoretical part of the video, she emphasizes two crucial aspects1 2
1. Implementing the Fabulous 4 (FAB4) for all HF patients this refer to refers to the four core treatments recommended by the ESC guidelines (2021 &2023) for heart failure management, and she highlights the importance of following the recommended treatment strategies outlined by the ESC to optimize outcomes.
2. Ensuring to reach the optimal dose of treatment within 6 weeks of diagnosis. This timeline of 6 weeks post-diagnosis is crucial in maximizing the effectiveness of the treatment and improving patient outcomes.>
In the second video, she focuses on the practical implications of the ESC guidelines for the management of heart failure patients.
Through these videos, provides valuable insights into the theoretical aspects of the new ESC guidelines and highlights the implementation and achieving the optimal dosage of treatment in the early stages of HF management.
ESC Guidelines Theoretical Impact - Part 1 (NL)
ESC Guidelines Theoretical Impact - Part 1 (FR)
ESC Guidelines Theoretical Impact - Part 1 (NL)
ESC Guidelines Theoretical Impact - Part 1 (FR)
ESC Guidelines in practice - Part 2 (NL)
ESC Guidelines in practice - Part 2 (FR)
ESC Guidelines in practice - Part 2 (NL)
ESC Guidelines in practice - Part 2 (FR)
References:
1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK; ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Oct 1;44(37):3627-3639.
2.McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726.
